EGFR and neoplasm: Our previous studies have shown that a variety of tumor-associated glycoproteins have Lewis y antigen structure, such as epidermal growth factor receptor EGFR [23], CD44 [12] and integrin α5β1 [18], and Lewis y antigen modifies the end of the protein, which then affects the biological functions mediated by these molecules, promoting the occurrence and development of tumors.